David W. Stroman - Net Worth and Insider Trading

David W. Stroman Net Worth

The estimated net worth of David W. Stroman is at least $1 dollars as of 2024-11-13. David W. Stroman is the SVP, Ophthalmic Product Devt. of NovaBay Pharmaceuticals Inc and owns about 1 shares of NovaBay Pharmaceuticals Inc (NBY) stock worth over $1. Details can be seen in David W. Stroman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David W. Stroman has not made any transactions after 2014-12-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of David W. Stroman

To

David W. Stroman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David W. Stroman owns 1 companies in total, including NovaBay Pharmaceuticals Inc (NBY) .

Click here to see the complete history of David W. Stroman’s form 4 insider trades.

Insider Ownership Summary of David W. Stroman

Ticker Comapny Transaction Date Type of Owner
NBY NovaBay Pharmaceuticals Inc 2014-12-12 SVP & Ophthalmic Product Devt.

David W. Stroman Latest Holdings Summary

David W. Stroman currently owns a total of 1 stock. David W. Stroman owns 1 shares of NovaBay Pharmaceuticals Inc (NBY) as of December 12, 2014, with a value of $1.

Latest Holdings of David W. Stroman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NBY NovaBay Pharmaceuticals Inc 2014-12-12 1 0.78 1

Holding Weightings of David W. Stroman


David W. Stroman Form 4 Trading Tracker

According to the SEC Form 4 filings, David W. Stroman has made a total of 0 transactions in NovaBay Pharmaceuticals Inc (NBY) over the past 5 years. The most-recent trade in NovaBay Pharmaceuticals Inc is the acquisition of 0 shares on December 12, 2014, which cost David W. Stroman around $6,600.

Insider Trading History of David W. Stroman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David W. Stroman Trading Performance

GuruFocus tracks the stock performance after each of David W. Stroman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David W. Stroman is -9.98%. GuruFocus also compares David W. Stroman's trading performance to market benchmark return within the same time period. The performance of stocks bought by David W. Stroman within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how David W. Stroman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of David W. Stroman

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -6.67 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -9.18 LIMIT LIMIT LIMIT LIMIT LIMIT

David W. Stroman Ownership Network

Ownership Network List of David W. Stroman

No Data

Ownership Network Relation of David W. Stroman

Insider Network Chart

David W. Stroman Owned Company Details

What does NovaBay Pharmaceuticals Inc do?

Who are the key executives at NovaBay Pharmaceuticals Inc?

David W. Stroman is the SVP & Ophthalmic Product Devt. of NovaBay Pharmaceuticals Inc. Other key executives at NovaBay Pharmaceuticals Inc include Interim CFO Tommy Law , President & DERMAdoctor & LLC Jeffrey Kunin , and Chief Product Officer Audrey Kunin .

NovaBay Pharmaceuticals Inc (NBY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of NovaBay Pharmaceuticals Inc (NBY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NovaBay Pharmaceuticals Inc (NBY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NovaBay Pharmaceuticals Inc (NBY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NovaBay Pharmaceuticals Inc Insider Transactions

No Available Data

David W. Stroman Mailing Address

Above is the net worth, insider trading, and ownership report for David W. Stroman. You might contact David W. Stroman via mailing address: 7214 Native Oak Lane, Irving Tx 75063.